genome

Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began trading on June 17, 2021. The new year saw the company announcing its diversification into drug development. Will this...

Illumina, Inc. (NASDAQ: ILMN) announced after Thursday's market close that it has committed $100 million into a new venture capital firm. Illumina's new fund, named Illumina Ventures, was established by Nicholas Naclerio, the company's former senior vice president of corporate and venture...

In a story first reported by Nikkei and updated recently by Le Monde, Sony Corp. (NYSE: SNE) and U.S. genome sequencing equipment maker Illumina Inc. (NASDAQ: ILMN) plan to launch a human genome analysis project in October. The project will involve the study and analysis of genetic material...